FDA approves Accu-Chek Combo insulin pump

FDA approves Accu-Chek Combo insulin pump
FDA approves Accu-Chek Combo insulin pump

The FDA has approved a new insulin pump system -- the Accu-Chek Combo system (Roche) -- that combines a blood glucose meter and insulin pump, which exchange data using Bluetooth technology. 

The system enables users to quickly test blood glucose levels and operate the insulin pump remotely by means of a bolus advisor to determine the right amount of insulin.

Other features of the Accu-Chek Combo System include: flexibility to adjust the basal rate to as low as 0.05 units per hour (in 0.01 unit increments), and an insulin cartridge that holds up to 315 units of insulin, the largest capacity among available pumps.

Other Accu-Chek glucose monitors include: Accu-Chek Active, Accu-Chek Advantage, Accu-Chek Aviva, Accu-Chek Compact Plus, Accu-Chek Voicemate and Accu-Chek Nano. Roche plans to launch the Accu-Chek Combo System later this year.

For more information call (800) 858-8072 or visit www.accu-chek.com.

More in Web Exclusives

Restless legs syndrome linked to higher mortality in men

Restless legs syndrome linked to higher mortality in ...

Study shows a significant correlation between men with restless legs syndrome and mortality.

Challenges to CCHD pulse oximetry screening identified

Challenges to CCHD pulse oximetry screening identified

Healthcare providers have experienced a number of challenges implementing CCHD pulse oximetry screening for newborns, since the procedure was officially recommended in October 2010.

Rotarix just as effective as Rotateq against rotavirus

Rotarix just as effective as Rotateq against rotavirus

The monovalent rotavirus vaccine is more than 90% effective at preventing rotavirus, putting the vaccine's efficacy on par with the pentavalent vaccine.